Vivani Plans Cortigent-ClearOne Merger to Create Nasdaq-Listed Cortigent Holdings
Vivani is merging subsidiary Cortigent with ClearOne, targeting a rebrand to Cortigent Holdings and a new CRGT ticker.
Vivani is making a bold move to get its neural device subsidiary onto Nasdaq without a traditional IPO. The company announced it is merging Cortigent, Inc. into a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), the existing listed entity. If regulators and shareholders sign off, CLRO effectively becomes a new company overnight.
The deal calls for a full rebrand. ClearOne would shed its name and trading symbol, relaunching as Cortigent Holdings, Inc. — doing business as Cortigent — under the new ticker "CRGT." That's a clean break from ClearOne's audio-communications identity and a direct pivot toward Cortigent's neurotechnology focus.
Read more Dow Futures Slip as Tesla, SanDisk Drag AI Stocks Lower →
For retail traders, this is the kind of reverse-merger play that can move fast. CLRO is the vehicle, and any positioning before the transaction closes means you're holding shares that could be repriced once the Cortigent brand takes over. Watch volume and any SEC filings closely — structure changes like ticker swaps tend to generate outsized short-term volatility.
The broader strategic logic is straightforward: Vivani gets Cortigent a public market listing and access to capital without the cost and scrutiny of a standalone IPO roadshow. ClearOne shareholders get exposure to a neurostimulation-focused company under new management and a new identity. Whether the combined entity can deliver on that promise is the real question investors should be asking.
Continue reading at GlobalNewswire.
